UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

Molecular therapy, 2024-08, Vol.32 (8), p.2428-2428

Tregoning, John S.

2024

Volltextzugriff (PDF)

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Volltextzugriff (PDF)

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Journal of general virology, 2014-06, Vol.95 (Pt 6), p.1244-1254

2014

Volltextzugriff (PDF)

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Pediatric research, 2015-11, Vol.78 (5), p.483-491

2015

Volltextzugriff (PDF)

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Nature (London), 2013-09, Vol.501 (7467), p.439-443

2013

Volltextzugriff (PDF)

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Cell host & microbe, 2022-01, Vol.30 (1), p.41-52.e5

2022

Volltextzugriff (PDF)

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.e637-e646

2024

Volltextzugriff (PDF)

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.e153-e163

2016

Volltextzugriff (PDF)

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.e647-e656

2024

Volltextzugriff (PDF)

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

The Journal of infectious diseases, 2024-07, Vol.230 (1), p.e102-e110

2024

Volltextzugriff (PDF)

Passive and active immunization against respiratory syncytial virus for the young and old

Expert review of vaccines, 2017-07, Vol.16 (7), p.737-749

2017

Volltextzugriff (PDF)

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

European journal of pharmaceutics and biopharmaceutics, 2024-10, Vol.203, p.114457, Article 114457

2024

Volltextzugriff (PDF)

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Journal of virology, 2015-09, Vol.89 (17), p.8974-8981

2015

Volltextzugriff (PDF)

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in immunology, 2024-05, Vol.15, p.1374818-1374818

2024

Volltextzugriff (PDF)

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

Frontiers in immunology, 2024-07, Vol.15, p.1406929

2024

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

Neonatology (Basel, Switzerland), 2024, Vol.121 (3), p.271-282

2024

Volltextzugriff (PDF)

Respiratory syncytial virus vaccines: the future is bright

The lancet respiratory medicine, 2024-07, Vol.12 (7), p.499-499

The Lancet Respiratory Medicine

2024

Volltextzugriff (PDF)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

Scientific reports, 2017-02, Vol.7 (1), p.42428-42428, Article 42428

2017

Volltextzugriff (PDF)

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

American journal of respiratory and critical care medicine, 2015-05, Vol.191 (9), p.1040-1049

2015

Volltextzugriff (PDF)

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

The Journal of immunology (1950), 2016-02, Vol.196 (4), p.1721-1731

2016

Volltextzugriff (PDF)

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Frontiers in immunology, 2021-03, Vol.12, p.650331

2021

Volltextzugriff (PDF)

Asthma and viral infections: An intricate relationship

Annals of allergy, asthma, & immunology, 2019-10, Vol.123 (4), p.352-358

2019

Volltextzugriff (PDF)

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Clinical Microbiology Reviews, 2005-07, Vol.18 (3), p.541-555

2005

Volltextzugriff (PDF)

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

Journal of virology, 2017-10, Vol.91 (19)

2017

Volltextzugriff (PDF)

1 – 25 von 2.729

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaRespiratory Syncytial Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.405)
Mit Volltextzugriff
(1.816)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.115)
Life Sciences & Biomedicine
(2.084)
Humans
(2.014)
Animals
(1.137)
Respiratory Syncytial Viruses - Immunology
(1.056)
Immunology
(1.007)
Infant
(895)
Female
(858)
Respiratory Syncytial Virus Infections - Immunology
(768)
Infectious Diseases
(680)
Biological And Medical Sciences
(663)
Male
(630)
Microbiology
(599)
Child, Preschool
(551)
Child
(481)
Virology
(474)
Mice
(445)
Medical Sciences
(424)
Respiratory Syncytial Virus Infections - Prevention & Control
(413)
Infant, Newborn
(411)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.704)
EZB Electronic Journals Library
(1.616)
Journals@Ovid Ovid Full Text
(1.082)
Publisher or Other Site
(998)
Ingenta
(946)
IngentaConnect Journals
(543)
Elsevier ScienceDirect Journals Complete
(472)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(375)
Oxford journals
(308)
JSTOR
(287)
Oxford Journals 2020 Medicine
(271)
Wiley Online Library
(250)
Wiley Online Library Full Collection 2018
(163)
Taylor & Francis Journals
(86)
Taylor & Francis
(85)
Taylor & Francis Online
(83)
Nature
(71)
BMJ journals single titles
(60)
Nexis Uni
(57)
Springer Nature - Complete Springer Journals
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

The race to make vaccines for a dangerous respiratory virus

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

Passive and active immunization against respiratory syncytial virus for the young and old

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

Respiratory syncytial virus vaccines: the future is bright

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Asthma and viral infections: An intricate relationship

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

Aktive Filter

Suchergebnisse filtern